A Win For Marker Therapeutics, Inc.

Fri, Oct 14, 2022 at 09:06 PM
A Win For Marker Therapeutics, Inc.

Marker Therapeutics, Inc. (MRKR:NASDAQ) rocketted at $0.39, a gain of 25.8%. On Fri, Oct 14, 2022, MRKR:NASDAQ hit a New 2-Week Intraday High of $0.44. From Fri, Sep 30, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Fri, Aug 05, 2022 at $0.66 with a volume of 74M+.

About Marker Therapeutics, Inc. (MRKR:NASDAQ)

TapImmune Inc is developing immunotherapies for a variety of cancers designed to target both tumors and metastatic disease. The company's next-generation technology has been engineered to overcome the deficiencies of earlier cancer vaccine approaches.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.